Monoclonal Antibodies in the Treatment of Relapsing Multiple Sclerosis: an Overview with Emphasis on Pregnancy, Vaccination, and Risk Management-论文-万方医学网

首页> > Monoclonal Antibodies in the Treatment of Relapsing Multiple Sclerosis: an Overview with Emphasis on Pregnancy, Vaccination, and Risk Management

Monoclonal Antibodies in the Treatment of Relapsing Multiple Sclerosis: an Overview with Emphasis on Pregnancy, Vaccination, and Risk Management

导出原文传递

翻译打印收藏纠错

作者： Krajnc, Nik ^[1] ; Bsteh, Gabriel ^[2] ; Berger, Thomas ; Mares, Jan ; Hartung, Hans-Peter

作者单位： Dept Neurol,Med Univ Vienna ^[1] Dept Neurol,Palacky Univ Olomouc ^[2]

关键词 Multiple sclerosis Disease-modifying therapy Monoclonal antibodies Natalizumab Alemtuzumab Rituximab Ocrelizumab Ofatumumab Ublituximab RHEUMATOID-ARTHRITIS PATIENTS PLACEBO-CONTROLLED TRIAL ALEMTUZUMAB TREATMENT INTERFERON BETA-1A POPULATION PHARMACOKINETICS LYMPHOCYTE RECONSTITUTION OPPORTUNISTIC INFECTIONS IMMUNIZATION RESPONSES RITUXIMAB-TREATMENT PERIPHERAL-BLOOD

发布时间 2022-09-30

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Monoclonal Antibodies in the Treatment of Relapsing Multiple Sclerosis: an Overview with Emphasis on Pregnancy, Vaccination, and Risk Management

相似文献

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Monoclonal Antibodies in the Treatment of Relapsing Multiple Sclerosis: an Overview with Emphasis on Pregnancy, Vaccination, and Risk Management

相似文献

相关期刊

检索历史清除